Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study.

Bordet C, Zureik M, Zelmat Y, Lafaurie M, Lapeyre-Mestre M, Sommet A, Mazieres J, Despas F

Open source

DOI
10.1016/j.ctarc.2024.100801
Published
2024
Container
Cancer treatment and research communications
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2024.100801,
  title = {Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study.},
  author = {Bordet C and Zureik M and Zelmat Y and Lafaurie M and Lapeyre-Mestre M and Sommet A and Mazieres J and Despas F},
  year = {2024},
  journal = {Cancer treatment and research communications},
  doi = {10.1016/j.ctarc.2024.100801},
  url = {https://doi.org/10.1016/j.ctarc.2024.100801}
}

RIS

TY  - JOUR
TI  - Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study.
AU  - Bordet C
AU  - Zureik M
AU  - Zelmat Y
AU  - Lafaurie M
AU  - Lapeyre-Mestre M
AU  - Sommet A
AU  - Mazieres J
AU  - Despas F
PY  - 2024
JO  - Cancer treatment and research communications
DO  - 10.1016/j.ctarc.2024.100801
UR  - https://doi.org/10.1016/j.ctarc.2024.100801
ER  - 

APA

C, B., M, Z., Y, Z., M, L., M, L., A, S., J, M., & F, D. (2024). Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2024.100801

Source records